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Abstract The goal of this study is to describe the spectrum
of initial and follow-up CT findings of novel influenza A
(H1N1) infection in a series of immunocompromised
patients. Eight immunocompromised patients with docu-
mented novel influenza A (H1N1) had CT imaging at our
institution between May 2009 and August 2009. A total of
20 CTs (initial and follow-up) were reviewed for the presence,
severity, and distribution of the following: ground glass
opacity, consolidation, interlobular septal thickening, mosaic
perfusion, airway wall thickening, airway dilatation, nodules,
cysts, pleural effusion, pericardial effusion, lymphadenopathy,
and air trapping. The most common findings were airway
thickening/dilatation, peribronchial ground glass opacity,
centrilobular nodules, and tree-in-bud opacities. Periphe-
ral consolidation involving the lower lobes was also a
common pattern. Findings frequently involved all lobes
and were closely associated with either large or small
airways. Two patients presented with atypical CT find-
ings including focal lobar consolidation and patchy lower
lobe consolidation with soft tissue centrilobular nodules.
Most survivors showed near complete resolution of findings
within 35 days. CT scans in immunocompromised patients
with novel influenza H1N1 commonly show a strong airway
predominance of findings or peripheral areas of consolidation
involving the lower lobes. A subset of patients with novel
influenza A (H1N1) will show findings not typical of viral
infection.
Keywords H1N1 . Influenza . Lung infection .
Immunocompromise
Introduction
Influenza poses a continual viral pandemic threat to humans
because of its ability to change its antigenic surface proteins
and the presence of an animal reservoir. It is hypothesized
that influenza has the potential to infect up to 30% of the
world’s population within a few months [1]. The first case
of infection with the novel influenza A (H1N1) strain was
detected in March 2009 [2]. Thought to originate in
Mexico, 2009 novel influenza A (H1N1) has become the
current dominant strain in the USA and other countries. As
of October 17, 2009, there were more than 414,000 cases
and 5,000 deaths reported worldwide according to the
World Health Organization [3]. Knowledge of the clinical
implications of novel influenza A (H1N1) strain has been
limited by a general lack of information about its virulence,
the most susceptible at-risk populations, and effectiveness
of immunization regimens.
Influenza causes significant morbidity and mortality in
immunocompromised patients with frequent progression to
lower respiratory tract disease, particularly in hematopoietic
stem cell transplant recipients [4]. In a recent study of
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patients with novel influenza A (H1N1) infection requiring
hospitalization, immunosuppressed patients comprised 19%
of all adults [5]. The clinical and radiographic manifes-
tations of infection in immunocompromised hosts may
differ from normal hosts due to an alteration in host altered
immunity and a blunted inflammatory response [6, 7]. The
goal of this paper is to describe the chest CT findings of
novel influenza A (H1N1) infection in a case series of
immunocompromised patients and to delineate the natural
history of disease on serial follow-up CT scans. A better
understanding of the variability of radiographic presenta-
tions of novel influenza A (H1N1) infection in immuno-
compromised hosts will hopefully enable physicians to
obtain early identification of infection and treatment.
Materials and methods
Patients
This case series study was approved by our institutional
review board, and informed consent was waived. The study
population consisted of eight immunocompromised patients
who were diagnosed with 2009 novel influenza A (H1N1)
strain at the University of California, San Francisco
Medical Center and San Francisco General Hospital
between May 2009 and August 2009 and also had chest
CTs. All study patients tested positive for 2009 novel
influenza A (H1N1) by PCR and confirmatory sequencing
of the hemagglutinin and neuraminidase genes. Three had
stem cell transplantation and three had solid organ
transplantation. Demographics and characteristics of the
eight patients are shown in Table 1.
Six patients acquired their infections in the community
and two had a hospital-acquired infection. All patients were
evaluated for other respiratory viral infections, and some
patients underwent additional microbiological evaluation
for bacterial and fungal infections. Although antibiotic
therapy was given in most cases, no significant bacterial or
other viral pathogens were recovered.
Testing for 2009 novel influenza A (H1N1)
Respiratory samples from the study patients were identified
as positive for influenza by viral direct fluorescent antibody
(D3-DFA Respiratory Virus Screening and ID Kit, Diag-
nostics Hybrids, Inc.) and/or multiplex PCR testing
(Respiratory Viral Panel Test, Luminex Corp). A PCR-
based assay was developed for specific detection of the
novel influenza A (H1N1) strain and exclusion of other
influenza strains, namely six different seasonal H3N2
strains and seasonal H1N1 (Appendix 1).
CT imaging
Chest CT was performed on either a General Electric
(Milwaukee, WI, USA) 16-MDCT or 64-MDCT scanner. A
total of 20 CT scans were reviewed in the eight patients.
These included 15 standard chest CT studies (12 without
contrast, three with intravenous contrast), three high-
resolution CT studies, and two pulmonary embolism
protocol CT studies. Standard CT was performed using
the following parameters: 64 or 16×0.625 mm detectors,
120 kVp, automatic mA adjustment, 2.5-mm section
reconstruction. For contrast-enhanced CT, a total of
120 cm3 of iohexol (Omnipaque; General Electric)
Table 1 Demographics, patient characteristics, and clinical factors in the eight patients with documented 2009 novel influenza A (H1N1)
No. Age
(years)
Comorbid condition Immunosuppression
regimen
Symptoms prior to
imaging (days)
Fever O2 Intubation Duration of
hospitalization
(days)
Outcome
1 58 Allogenic SCT 2006 Prednisone, tacrolimus,
mycophenolate mofetil
8 Yes No No 3 Survival
2 51 Liver transplant 2002 Prednisone,
mycophenolate mofetil
9 Yes No No 3 Survival
3 53 Heart transplant 2005 Cellcept, tacrolimus 3 Yes No No 5 Survival
4 31 Lung transplant 2003 Prednisone, tacrolimus,
mycophenolate mofetil
10 Yes No No 2 Survival
5 66 Diabetes, renal failure,
peritoneal dialysis
3 Yes Yes Yes 21 Died
6 36 Allogenic SCT 2007 Prednisone 7 Yes No No 17 Survival
7 43 Autologous SCT 2009 Chemotherapy 1 Yes Yes Yes 50 Survival
8 48 HIV, Burkitt’s
lymphoma
Chemotherapy 3 Yes Yes Yes 10 Died
SCT stem cell transplant
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350 mg/ml was given intravenously with images obtained
after a 90-s delay. High-resolution CT was performed using
the following parameters: 2×0.625 mm, sampled 1.25 mm
sections at 1-cm intervals in inspiration in both prone and
supine positions. Dynamic expiratory images were also
performed by obtaining six consecutive CT images at selected
levels (aortic arch, carina, and just above diaphragm) at 0.5-s
intervals during forced expiration using the same CT
parameters. Pulmonary embolism protocol CTwas performed
in a fashion similar to standard contrast-enhanced CT but with
appropriate scan timing and section reconstruction at
1.25 mm. Scans were timed using bolus tracking with an
ROI on the main pulmonary artery and a trigger of
approximately 200 HU. Contrast injection continued through-
out the image acquisition with approximately 60–80 cm3 of
iohexol (Omnipaque) administered per patient.
CT analysis
CT images were reviewed by consensus of two subspecialty-
trained thoracic radiologists with an average of 22 years of
experience in pulmonary imaging. All images were reviewed
on a Picture Archiving and Communication System worksta-
tion. The readers recorded the presence of each of the
following findings: ground glass opacity, consolidation,
interlobular septal thickening, mosaic perfusion, airway wall
thickening, airway dilatation, nodules, cysts, and air trapping
on the expiratory images. The distribution of consolidation
and ground glass opacity in affected regions was described as
diffuse, peribronchial, subpleural, or as having no specific
distribution with respect to the lung architecture. Nodules
were considered centrilobular when they demonstrated all
of the following features: sparing of the subpleural
interstitium, even spacing from one another, and associa-
tion with the distal bronchovascular interstitium. The lobes
affected by each of these findings were also recorded. The
severity of consolidation, ground glass opacity, and nodules
was graded as mild, moderate, or severe depending upon
the percentage of the lobe affected: mild (<25%),
moderate (25–75%), and severe (>75%). The presence of
pleural effusions, pericardial effusion, and lymphadenopathy
was also recorded.
Results
Overall summary of findings
The findings seen on all 20 CT scans included in this study
are shown in Table 2. Of note, this table includes both the
eight initial CTs and 12 follow-up examinations. Airway
thickening was seen in all patients. The second most
frequent finding present was consolidation (17 of 20 CT
scans). Consolidation was most commonly peripheral in
distribution (10 cases) and demonstrated the involvement of
the lower lobes in all but two cases. Ground glass opacity
was also commonly seen (13 of 20 cases), typically was
either diffuse (seven cases) or peribronchial (six cases) in
distribution, and involved all lobes in 12 cases. Centrilobular
nodules were present in eight of 20 cases and were both
of ground glass opacity (three cases) and soft tissue density
(five cases).
Initial CT findings
The initial scan on the eight patients was performed an
average of 4.7 (range 1–10 days) days after the onset of
symptoms. Most common findings on the initial CT scans
are shown in Tables 3 and 4.
Airway wall thickening was seen in all cases. Thicken-
ing was typically mild (6/8 cases). Airway dilatation often
accompanied thickening and was seen in four of eight
cases.
Ground glass opacity (GGO) and consolidation were
commonly seen. GGO was detected on four of eight of the
initial CT scans and was extensive, involving all lobes in
every case. GGO had a peribronchial distribution in three
cases (Figs. 1 and 2) and was diffuse in one case.
Consolidation (Fig. 3) was seen on five of eight of initial
CT scans, was commonly peripheral (3/8), and did not have
the same peribronchial predominance (1/8) as GGO. In
patients with consolidation, one or both lower lobes were
involved in all but one case (Fig. 4). The patient without
lower lobe involvement had focal posterior right upper
lobe consolidation (Fig. 5). One patient with peribron-
chial consolidation demonstrated a halo sign in which the
consolidation had a peripheral rim of GGO.
Centrilobular nodules were seen on three of eight of the
initial scans. In two of these cases, they were of ground
glass opacity, while in the other case, they were of soft
tissue attenuation (Fig. 6). Tree-in-bud was associated with
the CT showing soft tissue centrilobular nodules.
The overall distribution of abnormalities was diffuse in
five patients. In the remaining three patients, one had mild
airway wall thickening only, one showed isolated focal
right upper lobe non-segmental consolidation, and one
showed soft tissue centrilobular nodules and consolidation
in the lower lobes only.
Mosaic perfusion, air trapping, cysts, lymphadenopathy,
and interlobular septal thickening were not significant
features in any of the cases.
Follow-up CT findings
A total of 12 follow-up CT studies were obtained in six
patients. Of these, two patients showed near complete
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resolution of the initial abnormalities (Fig. 7) on the first
follow-up examination. The time interval between the initial
and follow-up scans in these patients was both 26 days (28
and 35 days, respectively, after the onset of symptoms).
Four patients showed interval worsening of abnormali-
ties on their first follow-up CT scan. The time interval
between the initial and follow-up CT in these patients was
3, 3, 4, and 22 days. Two of these patients survived, and
two died of their infection. Of the patients who survived,
CT showed overall improvement of findings by days 26 and
49 from their initial CT scan (days 33 and 50 after the onset
of symptoms). Progression in both of these patients was
manifested by new and increased size of patchy bilateral
centrilobular nodules. One patient developed tree-in-bud,
which was not present on the initial scan, and one patient
developed symmetric perihilar ground glass opacity.
One patient who died of the disease had focal consoli-
dation in the right upper lobe on the initial scan and then
demonstrated marked worsening of right upper lobe
consolidation, in addition to patchy dependent non-
segmental consolidation in the posterior lower lobes. The
second patient who died of novel influenza A (H1N1)
infection initially presented with extensive patchy bilateral
GGO and consolidation involving all lobes. Ten days later,
a follow-up CT demonstrated improvement in some of the
upper lobe consolidation, but worsening of both diffuse
GGO and dependent non-segmental consolidation (Fig. 8).
Discussion
Novel influenza A (H1N1) is a new, swine-origin virus first
described in 2009 and has become the current dominant
strain, as of late 2009 eclipsing seasonal influenza virus in
frequency [8]. Although the most high-risk groups appear
to be younger patients [2, 9] and pregnant women [10],
immunocompromised patients accounted for almost 20%
of adult patients hospitalized with novel influenza A
(H1N1) [5]. The mortality rate associated with novel
H1N1 influenza is also not clear; however, in one study,
6.5% (58/899) of admitted patients had severe illness, and
of those with severe disease, 41.4% died of the infection
[11]. The CT findings of novel influenza A (H1N1) have
not been well described. The goal of this paper is to
delineate the CT findings of this infection in a series of
immunocompromised patients.
Table 2 Summary of the CT findings of novel influenza A (H1N1) of
the 20 CT scans analyzed
CT findings Frequency
Ground glass opacity 13/20 (65%)
Diffuse 7/20 (35%)
Peribronchial 6/20 (30%)
Peripheral 0/20 (0%)
Consolidation 17/20 (85%)
Diffuse 2/20 (10%)
Peribronchial 5/20 (25%)
Peripheral 10/20 (50%)
Centrilobular nodules 8/20 (40%)
Ground glass 3/20 (15%)
Soft tissue 5/20 (25%)
Airway thickening 20/20 (100%)
Airway dilatation 9/20 (45%)
Pleural effusions 7/20 (35%)
Pericardial effusion 3/20 (15%)
Lymphadenopathy 1/20 (5%)
Interlobular septal thickening 0/20 (0%)
Cysts 0/20 (0%)
Overall distribution of findings
All lobes involved 13/20 (65%)
Upper lobe(s) only 2/20 (10%)
Lower lobe(s) only 5/20 (25%)
Eight of these CTs were initial scans performed after presentation. The
remaining 12 scans were follow-up examinations. The number of
scans on which the finding was present is given with percentage of
affected cases in parentheses
No. GGO Consolidation
Severity Distribution Lobes involved Severity Distribution Lobes involved
1 Moderate Peribronchial All N/A N/A N/A
2 Mild Peribronchial All Moderate Peribronchial Both lower lobes
3 N/A N/A N/A N/A N/A N/A
4 N/A N/A N/A Moderate Peripheral Left lower lobe
5 Severe Diffuse All Severe Diffuse All
6 N/A N/A N/A N/A N/A N/A
7 Mild Peribronchial All Mild Peripheral Right lower lobe
8 N/A N/A N/A Mild Peripheral Right upper lobe
Table 3 Severity, distribution,
and lobar involvement of con-
solidation and ground glass
opacity on the initial CT of
patients diagnosed with novel
influenza A (H1N1)
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In our study, the most common CT findings of novel
influenza A (H1N1) included airway thickening/dilatation,
peribronchial or diffuse ground glass opacity, peripheral
consolidation involving the lower lobes, and centrilobular
nodules. In all but one patient, the distribution of findings
was closely associated with large and/or small airways.
Two case series have previously described the CT
findings of novel influenza A (H1N1). The first of these
papers [12] primarily considered the chest radiographic
findings of novel influenza A (H1N1) infection and the
presence of pulmonary emboli in patients with severe
disease. CTs in these patients revealed diffuse GGO and
consolidation and nodular opacities. The demographics of
most patients in this study were not reported. The other
paper [13] described the findings of novel influenza A
(H1N1) in a series of seven patients, three of which had CT
scans. Most patients demonstrated patchy ground glass
opacity and consolidation with a peribronchovascular and
subpleural distribution, resembling organizing pneumonia.
Most of the patients in this study had comorbidities (e.g.,
diabetes, hypertension, and lung transplant), but in general,
the degree of immunocompromise was much less compared
to the patients in our study.
There are several important differences that distinguish
our paper. First, all of our patients were immunocompro-
mised, and all but one were being treated with immuno-
suppressive regimes for transplant or chemotherapy. The
CT abnormalities in our study seemed much less severe
than those in the aforementioned papers. It is likely there is
a lower threshold for imaging immunocompromised
patients, even those with mild or non-specific symptoms.
Thus, CT imaging is likely obtained closer to the onset of
clinical symptoms in the typical immunocompromised
patient. Second, it is well known that viral infection
commonly produces extensive regions of either diffuse or
localized diffuse alveolar damage (DAD) in late stage
cases. It is likely that DAD accounts for a significant
component of the CT findings of patchy or extensive
ground glass opacity and consolidation reported in other
studies. It is possible that immunocompromised patients, at
Fig. 2 A 51-year-old, male, liver transplant recipient with novel
influenza A (H1N1). Axial CT demonstrates patchy bilateral GGO
and consolidation with a peribronchial distribution. There is also
airway thickening associated with these abnormalities
Fig. 1 A 58-year-old man with novel influenza A (H1N1) and history of
allogenic stem cell transplant. Axial maximum intensity projection shows
patchy bilateral GGO with a peribronchial distribution. Note the small
nodular regions of GGO adjacent to some of the distal vessels (arrows)
No. Centrilobular nodules Airways
Density Tree-in-bud Lobes involved Thickening Dilatation Pleural effusions
1 Ground glass N/A All Mild Moderate N/A
2 N/A N/A N/A Moderate Mild N/A
3 N/A N/A N/A Mild N/A N/A
4 Soft tissue Yes Both lower lobes Mild Mild N/A
5 N/A N/A N/A Moderate N/A Bilateral
6 Ground glass N/A Both lower lobes Mild N/A N/A
7 N/A N/A N/A Mild Mild N/A
8 N/A N/A N/A Mild N/A N/A
Table 4 Presence, characteris-
tics, and distribution of centri-
lobular nodules, airway
thickening/dilatation, and
pleural effusions on the initial
CT of patients diagnosed with
novel influenza A (H1N1)
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least initially, do not develop the same inflammatory
response to infection as immunocompetent patients, result-
ing in less extensive DAD. It is interesting that the patient
in our study with the most extensive ground glass opacity
and consolidation had significantly less immunocompro-
mise than the remainder of patients.
One CT feature that is unique to our study is the small
airway involvement as manifested by centrilobular nodules
and tree-in-bud opacities. Three of eight patients demon-
strated centrilobular nodules on their initial CT scan, and
one of these showed tree-in-bud opacities. One additional
patient developed centrilobular nodules and another tree-in-
bud opacities on an interval follow-up CT. These small
airway findings were distinctly absent in the two other
series. It is possible that these small airways abnormalities
are obscured later in the disease process when more
extensive DAD is present.
Fig. 6 A 31-year-old, female, lung transplant recipient with novel
influenza A (H1N1). High-resolution CT scan demonstrates focal soft
tissue centrilobular nodules progressing to lobular consolidation
within the left lower lobe. While these findings are associated with
the distal airways, this finding is more commonly seen with bacterial
bronchopneumonia
Fig. 5 A 48-year-old man with novel influenza A (H1N1), HIV, and
Burkitt’s lymphoma. CT demonstrates focal non-segmental right upper
lobe consolidation. This was the only significant abnormality detected
Fig. 4 A 43-year-old man with novel influenza (H1N1) s/p
autologous stem cell transplant. Axial CT demonstrates peripheral
posterior bilateral lower lobe consolidation in addition to more diffuse
ground glass opacity
Fig. 3 A 36-year-old man with novel influenza A (H1N1) and
Hodgkin’s lymphoma s/p autologous stem cell transplant complicated
by graft vs. host disease. a Axial CT demonstrates patchy bilateral
peribronchial consolidation, GGO, centrilobular nodules, and airway
thickening typical of the airway-centric nature of novel influenza A
(H1N1). The differential density between the central and peripheral
lung is due to graft vs. host disease and pre-existed the other acute
findings. b CT image at the lung base demonstrates patchy soft tissue
centrilobular nodules with tree-in-bud opacities (arrow)
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Last, we detected two patients with novel influenza A
(H1N1) who demonstrated findings that could easily be
confused with bacterial infection. One patient showed
patchy, soft tissue centrilobular nodules with segmental
consolidation in the lower lobes resembling a broncho-
pneumonia. Another patient demonstrated focal right upper
lobe consolidation that could be confused with a lobar
pneumonia. It is very clinically relevant to understand the
spectrum of CT findings of novel influenza A (H1N1)
including atypical cases. It is likely that a certain percentage
of cases will have an appearance not typical of viral
infection.
The CT findings of viral infection in general are
numerous with previously reported studies demonstrating
a myriad of different findings including: consolidation,
ground glass opacity, interlobular septal thickening, cen-
trilobular nodules, airway thickening, and air trapping/
mosaic perfusion [14, 15]. These findings often overlap
with those of other infections such as bacterial, fungal, and
mycobacterial disease [16]. Thus, the imaging findings are
often non-specific with regards to the offending organism,
although CT may be helpful in distinguishing bacterial
from atypical organisms [17].
The CT findings of influenza described prior to the
emergence of the novel H1N1 strain have not been well
documented as most studies have included only a small
number of patients or have focused on chest X-rays. The
larger studies performed using CT have primarily shown a
pattern of extensive or diffuse bilateral GGO and consol-
idation [18–20].
Our findings are consistent with prior studies of viral
infection that have specifically analyzed immunosuppressed
patient populations. For instance, Kanne et al. demonstrated
Fig. 8 A 66-year-old man with novel influenza A (H1N1), diabetes,
and renal failure. a Axial CT demonstrates extensive, patchy bilateral
GGO and consolidation without a distinct peribronchial or subpleural
distribution. b Follow-up CT demonstrates worsening of dependent
consolidation, primarily in the lower lobes. While there has been
improvement in some of the non-dependent regions of consolidation,
the patient has developed more confluent GGO, typical of diffuse
alveolar damage. This patient also has pneumomediastinum from
alveolar rupture
Fig. 7 A 51-year-old, male, liver transplant recipient with novel
influenza A (H1N1). a Initial CT demonstrates patchy peribronchial
consolidation and GGO in the lower lobes. b Interval follow-up CT
performed 26 days later shows near complete resolution of the
previously seen abnormalities
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that the most common CT findings in patients with viral
pneumonias in the setting of hematopoetic stem cell
transplant were poorly defined centrilobular nodules, and
bilateral peribronchial GGO and consolidation [21]. Another
study evaluating viral infection in hematopoetic transplant
patients, which included five patients with influenza pneu-
monia, showed that the most common findings were patchy
bilateral ground glass opacities, nodules, and thickening of
the bronchovascular bundles [22]. In a study looking
specifically at influenza infection in the setting of immuno-
suppression, all three patients who underwent chest CT
imaging had GGO, consolidation, and centrilobular nodules
with tree-in-bud opacities [23].
Also of interest in our study was the diffuse nature of
findings in the majority of patients. A diffuse distribution
on imaging is very commonly seen in viral and atypical
infections [16]. It is important to note, however, that a
subset of patients with novel influenza A (H1N1) will have
non-diffuse findings that may simulate infection with other
types of organisms. The one patient that did not have
diffuse abnormalities was initially thought to have bacterial
infection. Infection with influenza is a well-known risk
factor for the development of bacterial superinfection.
Although the majority of patients were also empirically
treated with antibiotic therapy and one cannot completely
exclude the possibility of concomitant bacterial infection,
no clinically significant bacterial pathogens were isolated
from respiratory culture, suggesting that novel influenza A
(H1N1) very likely accounted for the radiographic findings
in all of these cases.
Progression of disease on serial CTs was most commonly
manifested by interval worsening of the airways disease
(peribronchial consolidation, airway thickening, and centri-
lobular nodules) and development of symmetric or diffuse
GGO. This later finding is typical of diffuse alveolar damage
as a reaction to the viral infection. Of the patients who
survived, all but one showed near complete resolution of the
findings on interval follow-up CTwithin 35 days of the onset
of clinical symptoms. One patient showed interval improve-
ment at 50 days after the initial CT.
There are several limitations to this study. Firstly, this is
small retrospective case series of eight immunocompro-
mised patients, and thus, it is difficult to make definitive
statements about the most common manifestations of novel
influenza A (H1N1) in general. The goal of this series is
simply to describe some of the CT findings that may be
seen with this infection and to suggest patterns that may be
suggestive of novel influenza A (H1N1) in the appropriate
clinical setting. Second, many of the CT scans were done
without a high-resolution technique, and thus, precise
characterization of abnormalities such as centrilobular
nodules is not ideal. With that in mind, standard CT scans,
particularly with the routine 2.5-mm reconstructions used at
our institution, can assess many of the same findings
optimally evaluated with the high-resolution technique. In
all cases of nodular disease, we were able to confidently
determine that the distribution of nodules was centrilobular
despite many of the CTs not being performed with the high-
resolution technique. Another limitation is that influenza A
infections are not uncommonly complicated by superinfec-
tion with other organisms, particularly bacterial. It is
possible that some of the findings seen on serial scans
performed after the initial diagnosis are due to an infection
other than influenza. This is complicated by the fact that
many of these patients, because of their immunocompo-
mised state, were also treated empirically with anti-bacterial
agents.
In summary, the CT findings of novel influenza A
(H1N1) infection in this series of immunocompromised
patients tended to be highly airway predominant and most
commonly presented with airway thickening/dilatation,
peribronchial ground glass, centrilobular nodules, and
tree-in-bud opacities. Peripheral consolidation involving
the lower lobes was also a common pattern. While these
findings can be associated with other infections, they may
be suggestive of novel influenza A (H1N1) in the
appropriate clinical setting. A high level of suspicion for
influenza should be maintained as occasionally it may
have an appearance identical to bacterial pneumonia.
Most immunocompromised patients with uncomplicated
novel influenza A (H1N1) infection show significant
radiographic improvement in 35 days or less after the
onset of symptoms.
Open Access This article is distributed under the terms of the
Creative Commons Attribution Noncommercial License which per-
mits any noncommercial use, distribution, and reproduction in any
medium, provided the original author(s) and source are credited.
Appendix 1
A PCR-based assay was developed for specific detection of
the novel influenza A (H1N1) strain. The hemagglutinin
and neuraminidase sequences of 10 seasonal H3N2,
seasonal H1N1, and novel H1N1 strains were obtained
from GenBank (accession numbers FJ966960, GQ149641,
CY047350, GQ895000, and GQ475749 for the hemagglu-
tinin gene and FJ969517, GQ894939, GQ894819,
GQ895001, and GQ475750 for the neuraminidase gene)
and aligned using ClustalW. Primer sets HA-F-2009H1N1
(5′-GGGTAGCCCCATTGCATTTGGGTAA-3′)/HA-R-
2009H1N1 (5′-CCTTTGTTCGAGTCATGATTGGGCC-3′)
and NA-F-2009H1N1 (5′-CTGCTGGACAGTCAGTGGTT
TCC-3′)/NA-R-2009H1N1 (5′-GCACTTGCTGACCAA
GCGACTG-3′) were designed to maximize specificity for
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detection of novel influenza A (H1N1) and not the seasonal
strains. Total RNA from the samples was extracted using
magnetic beads on an automated Biorobot EZ1 instrument
(Qiagen Corp) with the Virus 2.0 protocol. RT-PCR for
detection of the hemagglutinin and neuraminidase genes of
novel H1N1 was performed using the Qiagen 1-Step Kit
(Qiagen) according to the manufacturer’s protocol. Cycling
parameters for PCR were as follows: 15 min of initial
denaturation at 94°C followed by 35 cycles of denaturation
(30 s at 94°C), annealing (30 s at 50°C), and elongation
(30 s at 72°C), with a final extension at 72°C for 8 min.
Appropriate positive and negative controls were included
with each reaction. Amplified PCR bands of the expected
size as visualized on agarose gel electrophoresis were
sequenced on an ABI Prism Genetic Analyzer (Elim
Biopharmceuticals) to confirm the presence of novel
influenza A (H1N1) in samples from seven of the eight
study patients. Laboratory confirmation of novel influenza
A (H1N1) infection for the one remaining patient was
performed at the California Department of Public Health.
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